SMD — Spectral MD Holdings Income Statement
0.000.00%
HealthcareSpeculativeSmall Cap
- £79.69m
- £69.15m
- $25.37m
Annual income statement for Spectral MD Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 5.85 | 17.3 | 15.2 | 25.4 |
Cost of Revenue | ||||
Gross Profit | 2.52 | 7.99 | 7.05 | 10.8 |
Selling / General / Administrative Expenses | ||||
Total Operating Expenses | 8.89 | 15.9 | 19.4 | 28 |
Operating Profit | -3.04 | 1.45 | -4.18 | -2.65 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -3.08 | 1.41 | -4.09 | -2.81 |
Provision for Income Taxes | ||||
Net Income After Taxes | -3.11 | 1.23 | -3.99 | -2.91 |
Net Income Before Extraordinary Items | ||||
Net Income | -3.11 | 1.23 | -3.99 | -2.91 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -3.11 | 1.23 | -5.25 | -2.91 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.023 | 0.009 | -0.052 | -0.021 |
Dividends per Share |